Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis Review

Date: August 5, 2014
Pages: 43
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: R36814BCED1EN
Leaflet:

Download PDF Leaflet

Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis Review
Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Response Biomedical Corporation (Response Biomedical) is a Canada-based company that focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, NT-proBNP, CK-MB, and D-dimer; Environmental test for West Nile disease; Biodefense tests for anthrax, smallpox, ricin and botulinum toxin; and Infectious disease tests for influenza A+B and respiratory syncytial virus. The company develops its diagnostic tests using its proprietary RAMP technology platform.

Response Biomedical Corporation Key Recent Developments

May 12, 2014: Response Biomedical Announces First Quarter 2014 Financial Results
Mar 13, 2014: Response Biomedical Announces Fourth Quarter and Fiscal 2013 Financial Results
Feb 11, 2014: Response Biomedical Corp. Secures US$2.5 Million Term Loan
Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with O&D Biotech
Nov 25, 2013: Response Biomedical Announces Expansion of Chinese Distribution for RAMP Cardiovascular Products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Response Biomedical Corporation - Key Facts
Response Biomedical Corporation - Key Employees
Response Biomedical Corporation - Key Employee Biographies
Response Biomedical Corporation - Major Products and Services
Response Biomedical Corporation - History
Response Biomedical Corporation - Company Statement
Response Biomedical Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Response Biomedical Corporation - Business Description
Response Biomedical Corporation - SWOT Analysis
SWOT Analysis - Overview
Response Biomedical Corporation - Strengths
Strength - Diverse Geographical Operations
Strength - Proprietary Technology – RAMP
Strength - Strategic Collaborations
Response Biomedical Corporation - Weaknesses
Weakness - History of Losses
Weakness - Decline in Profitability Ratios
Response Biomedical Corporation - Opportunities
Opportunity - Organic Growth Strategies
Opportunity - Growing IVD Market
Opportunity - Market Potential: Metabolic Disorders
Response Biomedical Corporation - Threats
Threat - Government Regulations
Threat - Intense Competition
Threat - Uncertain R&D Outcomes
Response Biomedical Corporation - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Response Biomedical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014
Response Biomedical Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014
Response Biomedical Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Response Biomedical Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Response Biomedical Corporation, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 12, 2014: Response Biomedical Announces First Quarter 2014 Financial Results
Mar 13, 2014: Response Biomedical Announces Fourth Quarter and Fiscal 2013 Financial Results
Feb 11, 2014: Response Biomedical Corp. Secures US$2.5 Million Term Loan
Jan 02, 2014: Response Biomedical Provides Update on Chinese Distribution Agreement with O&D Biotech
Nov 25, 2013: Response Biomedical Announces Expansion of Chinese Distribution for RAMP Cardiovascular Products
Nov 13, 2013: Response Biomedical Announces 2013 Third Quarter Financial Results
Nov 06, 2013: Response Biomedical Schedules Third Quarter 2013 Earnings Release and Conference Call and Announces Participation in Upcoming Investor Conferences
Oct 31, 2013: Response Biomedical Announces New U.S. Sales Representation Agreement With Med Tech/Med Care
Aug 13, 2013: Response Biomedical Corp. Announces 2013 Second Quarter Financial Results
Aug 07, 2013: Response Biomedical Schedules Second Quarter 2013 Earnings Release and Announces Conference Call

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Response Biomedical Corporation, Key Facts
Response Biomedical Corporation, Key Employees
Response Biomedical Corporation, Key Employee Biographies
Response Biomedical Corporation, Major Products and Services
Response Biomedical Corporation, History
Response Biomedical Corporation, Other Locations
Response Biomedical Corporation, Subsidiaries
Response Biomedical Corporation, Key Competitors
Response Biomedical Corporation, Ratios based on current share price
Response Biomedical Corporation, Annual Ratios
Response Biomedical Corporation, Interim Ratios
Response Biomedical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014
Response Biomedical Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014
Response Biomedical Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Response Biomedical Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Response Biomedical Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Response Biomedical Corporation, Performance Chart (2009 - 2013)
Response Biomedical Corporation, Ratio Charts
Response Biomedical Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014
Response Biomedical Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014
Response Biomedical Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Response Biomedical Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Response Biomedical Corporation (RBM) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: